Literature DB >> 25097158

Ornstein-Uhlenbeck threshold regression for time-to-event data with and without a cure fraction.

Roger Erich1, Michael L Pennell.   

Abstract

In this paper we propose a threshold regression (TR) model for time to event data related to subject health using a latent Ornstein-Uhlenbeck (OU) process that fails once it hits a boundary value for the first time. Baseline covariates are incorporated into the analysis using a log-link function for the initial state of the health process. The model provides clinically meaningful covariate effects and does not require the proportional hazards assumption of the commonly used Cox model. Unlike TR models based on the Wiener process, the OU model allows increments in the health process to depend on previous values and drifts toward a state of equilibrium or homeostasis, which are present in many biological applications. We also extend our model to incorporate a cure rate for applications with improper survival functions, such as time to tumor recurrence in a cancer clinical trial. Our models are applied to overall and relapse-free survival data of melanoma patients undergoing definitive surgery.

Entities:  

Mesh:

Year:  2014        PMID: 25097158     DOI: 10.1007/s10985-014-9306-8

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  16 in total

1.  Covariates and random effects in a gamma process model with application to degradation and failure.

Authors:  Jerry Lawless; Martin Crowder
Journal:  Lifetime Data Anal       Date:  2004-09       Impact factor: 1.588

2.  Accelerated degradation models for failure based on geometric Brownian motion and gamma processes.

Authors:  Chanseok Park; W J Padgett
Journal:  Lifetime Data Anal       Date:  2005-12       Impact factor: 1.588

3.  Bayesian modelling of the dynamics of hepatotoxicity.

Authors:  Q Li; X Shen; D K Pearl
Journal:  Stat Med       Date:  2007-08-30       Impact factor: 2.373

Review 4.  Review and implementation of cure models based on first hitting times for Wiener processes.

Authors:  Jeremy Balka; Anthony F Desmond; Paul D McNicholas
Journal:  Lifetime Data Anal       Date:  2009-01-04       Impact factor: 1.588

5.  Semi-parametric estimation in failure time mixture models.

Authors:  J M Taylor
Journal:  Biometrics       Date:  1995-09       Impact factor: 2.571

6.  Does the covariance structure matter in longitudinal modelling for the prediction of future CD4 counts?

Authors:  J M Taylor; N Law
Journal:  Stat Med       Date:  1998-10-30       Impact factor: 2.373

7.  A random-walk model of human mortality and aging.

Authors:  M A Woodbury
Journal:  Theor Popul Biol       Date:  1977-02       Impact factor: 1.570

8.  The use of mixture models for the analysis of survival data with long-term survivors.

Authors:  V T Farewell
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

9.  High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190.

Authors:  J M Kirkwood; J G Ibrahim; V K Sondak; J Richards; L E Flaherty; M S Ernstoff; T J Smith; U Rao; M Steele; R H Blum
Journal:  J Clin Oncol       Date:  2000-06       Impact factor: 44.544

10.  Stochastic model for analysis of longitudinal data on aging and mortality.

Authors:  Anatoli I Yashin; Konstantin G Arbeev; Igor Akushevich; Aliaksandr Kulminski; Lucy Akushevich; Svetlana V Ukraintseva
Journal:  Math Biosci       Date:  2006-12-05       Impact factor: 2.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.